UZ Brussel has unveiled a new AI-based method to improve fertility treatments for men with low or absent sperm counts. Developed with Brussels IVF and Robovision, the tool, named T'easy, automates sperm cell detection during testicular biopsies.
The AI technology enhances a long-standing procedure called TESE, which extracts sperm directly from testicular tissue for use in IVF. Traditionally, a time-consuming task requiring trained experts, identifying sperm cells is now faster and more reliable.
T'easy uses an app, a custom microscope and machine learning to detect around 98 per cent of sperm cells in under 10 minutes. The Belgian hospital said the tool helps both doctors and prospective parents by delivering quicker results and reducing the risk of missed cells.
Although currently in the research phase, T'easy has the potential to significantly streamline fertility assessments and improve treatment outcomes. The project received support from Vlaio and Innoviris, regional bodies promoting innovation in healthcare.
